UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 281

Sortiert nach

Long-Term Partial Remission with Capecitabine/ Trastuzumab in a Patient with Metastatic Breast Cancer Following Progression on Trastuzumab Alone

Breast care (Basel, Switzerland), 2012-02, Vol.7 (1), p.45-47

2012

Link zum Volltext

Verfügbarkeit prüfen

Abstract P3-06-36: Assessment of phosphorylated HER2 protein as predictive biomarker to stratify anti-HER2 treatment in HER2 non-amplified patients – A translational study in the GeparQuattro and GeparQuinto trials

Cancer research (Chicago, Ill.), 2015-05, Vol.75 (9_Supplement), p.P3-P3-06-36

2015

Link zum Volltext

Verfügbarkeit prüfen

Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) – Part 1 with Recommendations for the Screening, Diagnosis and Therapy of Breast Cancer

Geburtshilfe und Frauenheilkunde, 2018-10, Vol.78 (10), p.927-948

2018

Link zum Volltext

Verfügbarkeit prüfen

Serum carbonic anhydrase IX as predictive marker for efficacy of bevacizumab: A biomarker analysis from the GeparQuinto phase III neoadjuvant breast cancer trial

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.11505-11505

2016

Link zum Volltext

Verfügbarkeit prüfen

Outcome after neoadjuvant chemotherapy in elderly breast cancer patients - a pooled analysis of individual patient data from eight prospectively randomized controlled trials

Oncotarget, 2018-03, Vol.9 (20), p.15168-15179

2018

Link zum Volltext

Verfügbarkeit prüfen

Male Breast Cancer: 20-Year Survival Data for Post-Mastectomy Radiotherapy

Breast care (Basel, Switzerland), 2013-08, Vol.8 (4), p.270-275

2013

Link zum Volltext

Verfügbarkeit prüfen

AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2017

Breast care (Basel, Switzerland), 2017-07, Vol.12 (3), p.172-183

2017

Link zum Volltext

Verfügbarkeit prüfen

AGO Recommendations for the Diagnosis and Treatment of Patients with Advanced and Metastatic Breast Cancer: Update 2017

Breast care (Basel, Switzerland), 2017-07, Vol.12 (3), p.184-191

2017

Link zum Volltext

Verfügbarkeit prüfen

Primary Therapy of Patients with Early Breast Cancer: Evidence, Controversies, Consensus: Opinions of German Specialists to the 14th St. Gallen International Breast Cancer Conference 2015 (Vienna 2015)

Geburtshilfe und Frauenheilkunde, 2015-06, Vol.75 (6), p.556-565

2015

Link zum Volltext

Verfügbarkeit prüfen

Docetaxel-related side effects and their management

European Journal of Oncology Nursing, 2009-02, Vol.13 (1), p.49-59

2009

Link zum Volltext

Verfügbarkeit prüfen

Adherence to Treatment Guidelines in Breast Cancer Care – a Retrospective Analysis of the ‘Organgruppe Mamma der Arbeitsgemeinschaft Gynaekologische Onkologie’

Breast care (Basel, Switzerland), 2008, Vol.3 (2), p.87-92

2008

Link zum Volltext

Verfügbarkeit prüfen

Re-Challenging Taxanes in Recurrent Breast Cancer in Patients Treated with (Neo-)Adjuvant Taxane-Based Therapy

Breast care (Basel, Switzerland), 2011-01, Vol.6 (4), p.279-283

2011

Link zum Volltext

Verfügbarkeit prüfen

The Breast Cancer Guideline of the German Gynecological Oncology Working Group (AGO) – History and Current Status

Breast care (Basel, Switzerland), 2006-08, Vol.1 (4), p.223-224

Minckwitz, Gunter von

2006

Link zum Volltext

Verfügbarkeit prüfen

Molecular basis for the development of novel taxanes in the treatment of metastatic breast cancer

European journal of cancer supplements, 2008-09, Vol.6 (10), p.3-11

2008

Link zum Volltext

Verfügbarkeit prüfen

AGO Recommendations for the Diagnosis and Treatment of Patients with Advanced and Metastatic Breast Cancer: Update 2018

Breast care (Basel, Switzerland), 2018-07, Vol.13 (3), p.209-215

2018

Link zum Volltext

Verfügbarkeit prüfen

Treatment Progress in Triple Negative Breast Cancer

European journal of gynaecological oncology, 2022-04, Vol.43 (2), p.341

2022

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Value of Tumour-Infiltrating Lymphocytes in an Unselected Cohort of Breast Cancer Patients

Diagnostics (Basel), 2022-10, Vol.12 (10), p.2527

2022

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of neoadjuvant pertuzumab in addition to chemotherapy and trastuzumab in routine clinical treatment of patients with primary breast cancer: a multicentric analysis

Breast cancer research and treatment, 2019-01, Vol.173 (2), p.319-328

2019

Link zum Volltext

Verfügbarkeit prüfen

Impact of stromal tumor-infiltrating lymphocytes (sTILs) on response to neoadjuvant chemotherapy in triple-negative early breast cancer in the WSG-ADAPT TN trial

Breast cancer research : BCR, 2022-09, Vol.24 (1), p.1-58, Article 58

2022

Link zum Volltext

Verfügbarkeit prüfen

Identifying High-Risk Triple-Negative Breast Cancer Patients by Molecular Subtyping

Breast care (Basel, Switzerland), 2021-12, Vol.16 (6), p.637-647

2021

Link zum Volltext

Verfügbarkeit prüfen

Safety and efficacy of afatinib as add-on to standard therapy of gemcitabine/cisplatin in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, phase I trial with an extensive biomarker program

BMC cancer, 2019-01, Vol.19 (1), p.55-10, Article 55

2019

Link zum Volltext

Verfügbarkeit prüfen

Targeted Therapy in HER2-Positive Breast Cancer

Oncology research and treatment, 2016-05, Vol.39 (5), p.295-302

2016

Link zum Volltext

Verfügbarkeit prüfen

A randomized phase II study of paclitaxel alone versus paclitaxel plus sorafenib in second- and third-line treatment of patients with HER2-negative metastatic breast cancer (PASO)

BMC cancer, 2017-07, Vol.17 (1), p.499-9, Article 499

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 281

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(229)
Mit Volltextzugriff
(279)

Publikationsform

Artikel
(244)
Buchkapitel
(34)
Bücher
(2)
Reviews
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Breast Care
(39)
Geburtshilfe Und Frauenheilkunde
(25)
Breast Cancer Research And Treatment
(11)
Cancers
(10)
British Journal Of Cancer
(7)
Bmc Cancer
(6)
Breast
(3)
Cancer Management And Research
(3)
Der Onkologe
(3)
European Journal Of Cancer
(3)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Long-Term Partial Remission with Capecitabine/ Trastuzumab in a Patient with Metastatic Breast Cancer Following Progression on Trastuzumab Alone

Abstract P3-06-36: Assessment of phosphorylated HER2 protein as predictive biomarker to stratify anti-HER2 treatment in HER2 non-amplified patients – A translational study in the GeparQuattro and GeparQuinto trials

Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) – Part 1 with Recommendations for the Screening, Diagnosis and Therapy of Breast Cancer

Serum carbonic anhydrase IX as predictive marker for efficacy of bevacizumab: A biomarker analysis from the GeparQuinto phase III neoadjuvant breast cancer trial

Outcome after neoadjuvant chemotherapy in elderly breast cancer patients - a pooled analysis of individual patient data from eight prospectively randomized controlled trials

Male Breast Cancer: 20-Year Survival Data for Post-Mastectomy Radiotherapy

AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2017

AGO Recommendations for the Diagnosis and Treatment of Patients with Advanced and Metastatic Breast Cancer: Update 2017

14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus - Primary Therapy of Early Breast Cancer: Opinions Expressed by German Experts

Primary Therapy of Patients with Early Breast Cancer: Evidence, Controversies, Consensus: Opinions of German Specialists to the 14th St. Gallen International Breast Cancer Conference 2015 (Vienna 2015)

Docetaxel-related side effects and their management

Adherence to Treatment Guidelines in Breast Cancer Care – a Retrospective Analysis of the ‘Organgruppe Mamma der Arbeitsgemeinschaft Gynaekologische Onkologie’

Re-Challenging Taxanes in Recurrent Breast Cancer in Patients Treated with (Neo-)Adjuvant Taxane-Based Therapy

AGO Recommendations for the Diagnosis and Therapy of Breast Cancer

The Breast Cancer Guideline of the German Gynecological Oncology Working Group (AGO) – History and Current Status

Molecular basis for the development of novel taxanes in the treatment of metastatic breast cancer

AGO Recommendations for the Diagnosis and Treatment of Patients with Advanced and Metastatic Breast Cancer: Update 2018

Treatment Progress in Triple Negative Breast Cancer

Prognostic Value of Tumour-Infiltrating Lymphocytes in an Unselected Cohort of Breast Cancer Patients

Efficacy of neoadjuvant pertuzumab in addition to chemotherapy and trastuzumab in routine clinical treatment of patients with primary breast cancer: a multicentric analysis

Impact of stromal tumor-infiltrating lymphocytes (sTILs) on response to neoadjuvant chemotherapy in triple-negative early breast cancer in the WSG-ADAPT TN trial

Identifying High-Risk Triple-Negative Breast Cancer Patients by Molecular Subtyping

Safety and efficacy of afatinib as add-on to standard therapy of gemcitabine/cisplatin in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, phase I trial with an extensive biomarker program

Targeted Therapy in HER2-Positive Breast Cancer

A randomized phase II study of paclitaxel alone versus paclitaxel plus sorafenib in second- and third-line treatment of patients with HER2-negative metastatic breast cancer (PASO)

Aktive Filter

Suchergebnisse filtern